Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-03-04

open access

Page views 1050
Article views/downloads 437
Get Citation

Connect on Social Media

Connect on Social Media

Clinicopathological features of neonatal subcutaneous fat necrosis and its implications

Cristina Ferreras12, Vanessa Gorito12, Ana Vilan32, Jorge Pedro4, Rita Santos Silva52, Cintia Castro-Correia52, Carla Costa52, Henrique Soares32
Pubmed: 33749815
Endokrynol Pol 2021;72(3):278-279.

Abstract

Not required for Clinical Vignette

Article available in PDF format

View PDF Download PDF file

References

  1. Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: A systematic review of the literature. Pediatr Dermatol. 2019; 36(1): 24–30.
  2. Kannenberg SMH, Jordaan HF, Visser WI, et al. Report of 2 Novel Presentations of Subcutaneous Fat Necrosis of the Newborn. Dermatopathology (Basel). 2019; 6(2): 147–152.
  3. Muzy G, Mayor SA, Lellis RF. Subcutaneous fat necrosis of the newborn: clinical and histopathological correlation. An Bras Dermatol. 2018; 93(3): 412–414.
  4. Farooque A, Moss C, Zehnder D, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol. 2009; 160(2): 423–425.
  5. Sharata H, Postellon DC, Hashimoto K. Subcutaneous fat necrosis, hypercalcemia, and prostaglandin E. Pediatr Dermatol. 1995; 12(1): 43–47.